Title: Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices.
Journal: PloS one20140101
Title: The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
Journal: Journal of cellular biochemistry20120601
Title: Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity.
Journal: The Journal of biological chemistry20120413
Title: Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
Journal: Bioorganic & medicinal chemistry letters20120401
Title: Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity.
Journal: Journal of medicinal chemistry20120112
Title: Chemical genomics profiling of environmental chemical modulation of human nuclear receptors.
Journal: Environmental health perspectives20110801
Title: Pharmacological activation of peroxisome proliferator-activated receptor δ improves insulin resistance and hepatic steatosis in high fat diet-induced diabetic mice.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme20110801
Title: Peroxisome proliferator-activated receptor δ downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences20110518
Title: AP1-dependent repression of TGFα-mediated MMP9 upregulation by PPARδ agonists in keratinocytes.
Journal: Experimental dermatology20110501
Title: Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?
Journal: The British journal of dermatology20110101
Title: PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells.
Journal: Journal of neurochemistry20101001
Title: Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.
Journal: Immunology20100801
Title: Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.
Journal: Diabetes/metabolism research and reviews20100701
Title: Porcine peroxisome proliferator-activated receptor delta mediates the lipolytic effects of dietary fish oil to reduce body fat deposition.
Journal: Journal of animal science20100601
Title: Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway.
Journal: The Journal of pharmacology and experimental therapeutics20100201
Title: Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism.
Journal: PPAR research20100101
Title: PPARdelta ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice.
Journal: European journal of pharmacology20091110
Title: Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
Journal: Cell proliferation20091001
Title: Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Journal: Molecular pharmacology20090801
Title: Role of PPAR-beta in hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells.
Journal: Atherosclerosis20090601
Title: PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair.
Journal: Journal of hepatology20090601
Title: Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis.
Journal: Free radical biology & medicine20090301
Title: PPARdelta agonist-mediated ROS stimulates mouse embryonic stem cell proliferation through cooperation of p38 MAPK and Wnt/beta-catenin.
Journal: Cell cycle (Georgetown, Tex.)20090215
Title: PPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle.
Journal: Atherosclerosis20090201
Title: Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-delta transcriptional pathway.
Journal: Molecular pharmacology20081101
Title: The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Journal: Experimental cell research20081015
Title: Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Journal: Molecular pharmacology20081001
Title: Effects of PPAR agonists on proliferation and differentiation in human urothelium.
Journal: Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie20080901
Title: Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes.
Journal: The FEBS journal20080801
Title: Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.
Journal: Endocrinology20080301
Title: Ectopic expression of porcine peroxisome proliferator-activated receptor delta regulates adipogenesis in mouse myoblasts.
Journal: Journal of animal science20080101
Title: A novel bioluminescent protease assay using engineered firefly luciferase.
Journal: Current chemical genomics20080101
Title: Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
Journal: Pflugers Archiv : European journal of physiology20071201
Title: Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes.
Journal: American journal of physiology. Endocrinology and metabolism20071101
Title: Differential 3,5,3'-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of Fatty acids.
Journal: Endocrinology20070801
Title: Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonists.
Journal: Bioorganic & medicinal chemistry20070801
Title: Effect of PPAR-delta agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes.
Journal: Biochemical and biophysical research communications20070525
Title: The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Journal: Journal of hepatology20070501
Title: Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors.
Journal: Cellular and molecular life sciences : CMLS20070501
Title: Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activated receptor delta activation: implication in IVF.
Journal: Human reproduction (Oxford, England)20070301
Title: Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
Journal: The Journal of pharmacology and experimental therapeutics20070301
Title: Tetradecylselenoacetic acid, a PPAR ligand with antioxidant, antiinflammatory, and hypolipidemic properties.
Journal: Arteriosclerosis, thrombosis, and vascular biology20070301
Title: PPAR agonists modulate human osteoclast formation and activity in vitro.
Journal: Bone20070101
Title: Studies towards the conception of new selective PPARbeta/delta ligands.
Journal: Bioorganic & medicinal chemistry letters20060901
Title: Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR.
Journal: Molecular and cellular endocrinology20060815
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501
Title: Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
Journal: Journal of the American Society of Nephrology : JASN20050801
Title: Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.
Journal: Biochimica et biophysica acta20050501
Title: Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Journal: Cardiovascular research20050301
Title: Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.
Journal: The Journal of pharmacology and experimental therapeutics20041101
Title: PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation.
Journal: Journal of lipid research20030201
Title: Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells.
Journal: Gastroenterology20030101
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry20020419
Title: PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells.
Journal: European journal of pharmacology20020125
Title: Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
Journal: Biochemical and biophysical research communications20020111
Title: The PPARs: from orphan receptors to drug discovery.
Journal: Journal of medicinal chemistry20000224
Title: Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures.
Journal: The Journal of biological chemistry19991210
Title: Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
Journal: The Journal of biological chemistry19990305
Title: Berger J, et al. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J Biol Chem. 1999 Mar 5;274(10):6718-25.
Title: Park, Jin-Hee., et al. The PPARδ ligand L-165041 inhibits vegf-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ. Journal of Cellular Biochemistry (2012), 113(6), 1947-1954.
Title: Lim, Hyun-Joung., et al. PPARδ ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice. European Journal of Pharmacology (2009), 622(1-3), 45-51.
Title: Lim, Hyun-Joung., et al. PPARδ agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle. Atherosclerosis (Amsterdam, Netherlands) (2009), 202(2), 446-454.
